title: [Current issues in pulmonary hypertension].
abstract: Pulmonary hypertension is a multietiological disease. Other forms have to be excluded to establish this diagnosis. Pulmonary hypertension is classified into five categories. One of these forms is pulmonary arterial hypertension with special treatment options. There are three main pathophysiological pathways and corresponding treatment includes the administration phosphodiesterase-5 inhibitors, endothelin receptor antagonists and prostacyclin derivates. Novel therapeutic options are under development. Patients with pulmonary hypertension need regular care and their treatment has to be conducted in specified centres.
authors.affiliation: Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ II. Belgyógyászati Klinika és Kardiológiai Központ. forster.tamas@med.u-szeged.hu
authors.forename: Tamás
authors.initials: T
authors.lastname: Forster
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D011464:Epoprostenol